Welcome to our dedicated page for QKIE news (Ticker: QKIE), a resource for investors and traders seeking the latest updates and insights on QKIE stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect QKIE's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of QKIE's position in the market.
QKI Emulsion (NASDAQ:QKIE) announced a planned Change in Control and senior leadership overhaul on November 25, 2025. The company said CEO Claudio Mirella, Executive President Andrea Piazzoli, and COO Daniele De Molli resigned effective immediately, attributed to personal and external professional reasons.
The board appointed Suneel Anant Sawant as Interim CEO and retained him as Chairman, named Enrico Carlo Fumagalli Director and Executive President, added Giovanni Genovese as Director, and appointed Eugene Paul Fumagalli General Manager. The board said the new team will accelerate commercial deployment of the company's ETV‑certified Emulsion technology and support international expansion.
